It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.
2008 | New Delhi, Delhi, India | ActiveFortune Medicines Private Limited, a active private limited company, was established on 16 December 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232DL2008PTC185878. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Praveen Singh Chauhan (Director), Anita Singh Chauhan (Director), Komal Ranvirsingh Chauhan (Director). Past directors included Lata Jaiswal, Nilesh Srivastva, Ajai Kumar Singh. It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at M-2, Yogeshwar Building Middle Circle , Cannaught Place, New Delhi, Delhi, 110001.
U24232DL2008PTC185878
185878
16 December 2008
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Fortune Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praveen Singh Chauhan | Director | 30 Dec 2015 | Current |
| Anita Singh Chauhan | Director | 30 Sep 2019 | Current |
| Komal Ranvirsingh Chauhan | Director | 30 Sep 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2019 | Past |
| Pramod Abcsdd | Director | 01 Oct 2019 | Past |
| Pramod Abcsdd | Director | 08 Oct 2014 | Past |
| Pramod Abcsdd | Director | 01 Apr 2014 | Past |
| Pramod Abcsdd | Director | 01 Oct 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fortune Medicines Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 351.63% increase. The company also saw a substantial improvement in profitability, with a 89.02% increase in profit. The company's net worth dipped by a decrease of 2.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Fortune Medicines had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2015 | Syndicate Bank | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fortune Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fortune Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Fortune Medicines Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Progress on Fortune Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi. was documented.
Anita Singh Chauhan was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Progress on Komal Ranvirsingh Chauhan was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 6 years 2 months . was documented.
The activity Praveen Singh Chauhan was appointed as a Director was appointed as a Director on 30 Dec 2015 & has been associated with this company since 9 years 11 months . was completed.
The activity A charge with Syndicate Bank amounted to Rs. 1.20 M with Charge ID 10549390 was registered on 21 Jan 2015. was completed.
The CIN of Fortune Medicines Private Limited is U24232DL2008PTC185878.
Fortune Medicines Private Limited is headquartered at M-2, Yogeshwar Building Middle Circle , Cannaught Place, New Delhi, Delhi, 110001.
Fortune Medicines Private Limited was incorporated on 16 December 2008.
The current directors of Fortune Medicines Private Limited are
The primary industry of Fortune Medicines Private Limited is Pharma.
Fortune Medicines Private Limited is unlisted.
The authorized capital of Fortune Medicines Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Fortune Medicines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX